Who owns Elicio Therapeutics Inc Com?
- Ticker: ELTX
- CUSIP Number: 28657f103
Tip: Access positions for across all investors
Analyze quarterly positions in Elicio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Elicio Therapeutics stock
Who bought or sold Elicio Therapeutics Inc Com this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Knoll Capital Management | 631k | $5.0M | 0% | Dec 2025 |
|
| Vanguard Group | 497k | $4.0M | 5% | Dec 2025 |
|
| Balyasny Asset Management | 148k | $1.6M | 100% | Sep 2025 |
|
| Geode Capital Management | 133k | $1.1M | 2% | Dec 2025 |
|
| Marshall Wace | 117k | $933k | 35% | Dec 2025 |
|
| Susquehanna International | 64k | $510k | -47% | Dec 2025 |
|
| 683 Capital Management | 56k | $449k | 100% | Dec 2025 |
|
| Northern Trust | 53k | $420k | -2% | Dec 2025 |
|
| State Street Corporation | 46k | $369k | 21% | Dec 2025 |
|
| BlackRock | 45k | $360k | 2% | Dec 2025 |
|
| UBS Group | 32k | $255k | 356% | Dec 2025 |
|
| Renaissance Technologies | 28k | $224k | -42% | Dec 2025 |
|
| CM Management | 25k | $199k | 317% | Dec 2025 |
|
| OMERS Administration Corporation | 24k | $187k | 100% | Dec 2025 |
|
| Millennium Management | 23k | $250k | 100% | Sep 2025 |
|
| Citadel Advisors | 21k | $230k | 100% | Sep 2025 |
|
| Qube Research & Technologies | 20k | $161k | 100% | Dec 2025 |
|
| Quadrature Capital | 17k | $137k | 100% | Dec 2025 |
|
| Squarepoint Ops | 17k | $133k | 100% | Dec 2025 |
|
| Occudo Quantitative Strategies | 16k | $126k | 100% | Dec 2025 |
|
| Meyer Handelman | 14k | $111k | 0% | Dec 2025 |
|
| Leucadia National Corporation | 12k | $95k | -41% | Dec 2025 |
|
| Point72 Asset Management | 12k | $93k | 100% | Dec 2025 |
|
| HighTower Advisors | 11k | $89k | 100% | Dec 2025 |
|
| Summit Financial | 10k | $80k | 100% | Dec 2025 |
|
| Mayflower Financial Advisors | 10k | $80k | 0% | Dec 2025 |
|
| Wiley Bros.-aintree Capital | 10k | $80k | 0% | Dec 2025 |
|
| Moody Lynn & Co/ | 10k | $80k | 0% | Dec 2025 |
|
| Atlantic Trust | 7.0k | $56k | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 5.7k | $45k | 100% | Dec 2025 |
|
| Steward Partners Investment Advisory | 1.6k | $12k | 0% | Dec 2025 |
|
| Farther Finance Advisors | 705.00 | $5.6k | 10% | Dec 2025 |
|
| Group One Trading | 323.00 | $2.6k | 100% | Dec 2025 |
|
| Wells Fargo & Company | 200.00 | $1.6k | 0% | Dec 2025 |
|
| Fortitude Family Office | 93.00 | $740.001000 | 100% | Dec 2025 |
|
| SBI Securities | 82.00 | $652.998800 | 0% | Dec 2025 |
|
Who sold out of Elicio Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Caption Management | Sep 2025 | 105k | $1.1M |
| Cresset Asset Management | Sep 2025 | 27k | $295k |
| Simplex Trading | Sep 2025 | 103.00 | $999.996100 |